Latest news
XENE Maintained by RBC Capital -- Price Target Lowered to $81.00 - GuruFocusGuruFocus · Fri, 07 Aug 2026 23:00:31 GMTWedbush Adjusts PTon Xenon Pharmaceuticals to $71 From $63, Maintains Outperform Rating - MoomooMoomoo · Fri, 07 Aug 2026 20:05:42 GMTXenon Pharmaceuticals Q2 Earnings Call Highlights - TradingViewTradingView · Fri, 07 Aug 2026 20:04:17 GMTFDA Pre-NDA Progress On Azetukalner Could Be A Game Changer For Xenon Pharmaceuticals (XENE) - simplywall.stsimplywall.st · Fri, 07 Aug 2026 18:52:11 GMTXENE's Q2 Loss Narrower Than Expected, Sales Nil, Pipeline in Focus - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 14:12:00 GMTXENON PHARMACEUTICALS INC. : WEDBUSH RAISES TARGET PRICE TO $71 FROM $63 - BitgetBitget · Fri, 07 Aug 2026 11:56:41 GMTXENE Aug 2026 65.000 call (XENE260821C00065000) Stock Historical Prices & Data - Yahoo! Finance CanadaYahoo! Finance Canada · Fri, 07 Aug 2026 09:18:17 GMTCalifornia State Teachers Retirement System Buys 36,183 Shares of Xenon Pharmaceuticals Inc. $XENE - MarketBeatMarketBeat · Fri, 07 Aug 2026 07:18:14 GMT